Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
Gentamicin, tobramycin, amikacin, and kanamycin were given subcutaneously in separate trials to healthy adult dogs of both sexes. Daily dosage levels were as follows: gentamicin, 6.6 mg/kg of body weight; tobramycin, 3 mg/kg; amikacin, 15 mg/kg; and kanamycin, 11 mg/kg. Gentamicin, tobramycin, and amikacin were given in divided doses of 8-hour intervals for 5 consecutive 8-hour periods, whereas kanamycin was given in divided doses at 12-hour intervals for 4 consecutive 12-hour periods. Mean 8-hour urine concentrations +/- 1 SD were gentamicin, 107 +/- 33 microgram/ml, tobramycin, 66 +/- 39 microgram/ml; and amikacin, 342 +/- 153 microgram/ml. Mean urine concentrations (+/- 1 SD) for kanamycin were 473 +/- 306 microgram/ml in urine collected between 0 and 6 hours after dosing and 63 +/- 47 microgram/ml in urine collected 6 to 12 hours after dosing.
D000583:Amikacin / Q000008:administration & dosage / Q000652:urine*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000652:urine*; D004285:Dogs / Q000652:urine*; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage / Q000652:urine*; D007279:Injections, Subcutaneous; D007612:Kanamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000652:urine*; D008297:Male; D014031:Tobramycin / Q000008:administration & dosage / Q000652:urine*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D007612:Kanamycin; D000583:Amikacin; D014031:Tobramycin